Revenue
2022
2023
2024
2025
Genflow Biosciences plc (GENF)
Price£0.02175Cached quote
Net income
2021
2022
2023
2024
2025
Free cash flow
2021
2022
2023
2024
Total cash / debt
CashTotal debt
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | £0 | £0 | £0 | £0 | — |
| Gross profit | £585,607 | £320,471 | — | — | — |
| Research & development | £1.1M | £1.2M | £1.2M | £724,465 | — |
| Operating expenses | £2.0M | £1.9M | £1.9M | £1.3M | — |
| Operating income | −£1.4M | −£1.6M | −£1.9M | −£1.3M | — |
| EBITDA | −£1.4M | −£1.6M | −£1.9M | −£1.3M | — |
| Net income | −£1.4M | −£1.6M | −£1.9M | −£1.3M | −£988,195 |
| Basic EPSper basic share | -£0.33 | -£0.48 | -£0.01 | -£0.00 | — |
| Diluted EPSper diluted share | -£0.00 | -£0.00 | -£0.01 | -£0.00 | — |